Anuh Pharma Limited (NSE:ANUHPHR)
210.70
+2.65 (1.27%)
At close: Jun 27, 2025, 3:30 PM IST
Anuh Pharma Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 197.35 | 72.02 | 19.27 | 37.96 | 21.98 | Upgrade
|
Short-Term Investments | 538.58 | 12.37 | 8.1 | - | 49.45 | Upgrade
|
Trading Asset Securities | - | 538.17 | 503.4 | 214.69 | 60.7 | Upgrade
|
Cash & Short-Term Investments | 735.93 | 622.56 | 530.77 | 252.65 | 132.13 | Upgrade
|
Cash Growth | 18.21% | 17.29% | 110.08% | 91.21% | -80.48% | Upgrade
|
Accounts Receivable | 2,159 | 1,899 | 1,712 | 1,357 | 1,069 | Upgrade
|
Other Receivables | 2.88 | 25.59 | 39.14 | 5.25 | 163.64 | Upgrade
|
Receivables | 2,167 | 1,931 | 1,756 | 1,370 | 1,242 | Upgrade
|
Inventory | 744.81 | 754 | 726.36 | 799.23 | 814.26 | Upgrade
|
Prepaid Expenses | - | 5.88 | 5.72 | 4.79 | 4.4 | Upgrade
|
Restricted Cash | - | 10.5 | 30.5 | - | - | Upgrade
|
Other Current Assets | 113.94 | 37.79 | 26.61 | 159.98 | 184.97 | Upgrade
|
Total Current Assets | 3,762 | 3,362 | 3,076 | 2,587 | 2,377 | Upgrade
|
Property, Plant & Equipment | 583.65 | 492.41 | 526.76 | 613.41 | 711.83 | Upgrade
|
Long-Term Investments | 519.55 | 517.14 | 396.84 | 212.13 | 203.71 | Upgrade
|
Other Intangible Assets | 1.21 | 1.58 | 1.31 | 1.83 | 2.4 | Upgrade
|
Long-Term Deferred Tax Assets | 20.8 | 4.22 | 7.68 | - | - | Upgrade
|
Other Long-Term Assets | 177.76 | 77.35 | 41.09 | 57.51 | 31.16 | Upgrade
|
Total Assets | 5,066 | 4,457 | 4,050 | 3,472 | 3,326 | Upgrade
|
Accounts Payable | 1,568 | 1,405 | 1,528 | 1,216 | 1,200 | Upgrade
|
Accrued Expenses | 1.67 | 6.16 | 4.74 | 3.34 | 3.39 | Upgrade
|
Short-Term Debt | 104.98 | 20.13 | - | 31.11 | 135.98 | Upgrade
|
Current Portion of Leases | 3.3 | 2.91 | 0.67 | 2.06 | 0.78 | Upgrade
|
Current Income Taxes Payable | 5.48 | - | - | - | - | Upgrade
|
Other Current Liabilities | 101.26 | 92.72 | 80.29 | 56.81 | 54.39 | Upgrade
|
Total Current Liabilities | 1,785 | 1,527 | 1,613 | 1,309 | 1,395 | Upgrade
|
Long-Term Leases | 0.58 | 3.88 | 8.39 | 9.07 | - | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | 0.48 | 10.14 | Upgrade
|
Other Long-Term Liabilities | 20.31 | 2.75 | 5.93 | 5.69 | 5.53 | Upgrade
|
Total Liabilities | 1,806 | 1,545 | 1,638 | 1,334 | 1,420 | Upgrade
|
Common Stock | 250.56 | 250.56 | 250.56 | 250.56 | 250.56 | Upgrade
|
Retained Earnings | - | 2,660 | 2,160 | 1,886 | 1,655 | Upgrade
|
Comprehensive Income & Other | 3,010 | 1.31 | 1.69 | 1.3 | 0.46 | Upgrade
|
Shareholders' Equity | 3,260 | 2,912 | 2,412 | 2,138 | 1,906 | Upgrade
|
Total Liabilities & Equity | 5,066 | 4,457 | 4,050 | 3,472 | 3,326 | Upgrade
|
Total Debt | 108.86 | 26.93 | 9.07 | 42.24 | 136.75 | Upgrade
|
Net Cash (Debt) | 627.06 | 595.63 | 521.7 | 210.41 | -4.63 | Upgrade
|
Net Cash Growth | 5.28% | 14.17% | 147.94% | - | - | Upgrade
|
Net Cash Per Share | 12.51 | 11.89 | 10.41 | 4.20 | -0.09 | Upgrade
|
Filing Date Shares Outstanding | 50.03 | 50.11 | 50.11 | 50.11 | 50.11 | Upgrade
|
Total Common Shares Outstanding | 50.03 | 50.11 | 50.11 | 50.11 | 50.11 | Upgrade
|
Working Capital | 1,977 | 1,835 | 1,463 | 1,278 | 982.61 | Upgrade
|
Book Value Per Share | 65.17 | 58.11 | 48.14 | 42.66 | 38.04 | Upgrade
|
Tangible Book Value | 3,259 | 2,911 | 2,411 | 2,136 | 1,904 | Upgrade
|
Tangible Book Value Per Share | 65.14 | 58.08 | 48.11 | 42.62 | 38.00 | Upgrade
|
Land | - | 113.07 | 113.07 | 113.07 | 113.07 | Upgrade
|
Buildings | - | 146.73 | 146.73 | 146.73 | 146.12 | Upgrade
|
Machinery | - | 767.32 | 723.6 | 713.5 | 709.4 | Upgrade
|
Construction In Progress | - | 4.54 | - | 1 | - | Upgrade
|
Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.